Search

everythinglearnresearchcommunity

for

Search:↓

Eczema patients have a lower skin lipid to protein ratio, older and longer-staying hospital patients are more likely to get pressure ulcers, hair loss in AGA is linked to muscle degeneration, vitamin D deficiency is common in alopecia areata and linked to its severity, standard liver tests don't effectively detect fibrosis in psoriasis patients on methotrexate, and bullous pemphigoid patients have a higher death risk but combination therapy may reduce it.

Hair pain is more common in women with hair loss, but it's not linked to the cause or severity of hair loss.

Patients with myotonic dystrophy often have skin problems that suggest early aging and vitamin D issues, and the severity of these problems is linked to their genetic condition and vitamin D levels.

Higher levels of CCL7 are linked to more severe hair loss in alopecia areata patients.

Finasteride can cause lasting sexual, emotional, and cognitive issues, with varying severity.

Baricitinib significantly improves nail and hair symptoms in severe alopecia areata.

Minoxidil may help hair regrowth in traction alopecia, but changing hair habits is the main treatment.

1 mg/day of low-dose oral minoxidil is effective and safe for treating female hair loss.

Corticosteroid therapy for alopecia areata can cause severe hip bone damage.

Intralesional triamcinolone acetonide is more effective but has a higher relapse rate than platelet-rich plasma for treating alopecia areata.

Elderly patients have more severe hidradenitis suppurativa and may need different treatments.

The gene for Marie Unna hereditary hypotrichosis is located on chromosome 8p21.

Early high-dose steroid treatment helps prolong disease-free periods in severe alopecia areata.

The gene for Marie Unna hereditary hypotrichosis is located on chromosome 8p21, near the hairless gene.

The combination of vitamin D analogues with potent steroids is a favorable treatment for alopecia areata with fewer side effects.

Ayurvedic treatment led to complete hair regrowth in a patient with Alopecia Areata.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Baricitinib is more effective than tofacitinib for hair regrowth in alopecia patients.

Elevated testosterone, DHEA-S, and FAI help identify PCOS risk in menstrual irregularities.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

Hyaluronic acid injections can improve mouth opening and quality of life in scleroderma patients.

Using fractional CO2 laser with halometasone cream works better for chronic hand eczema than just the cream, improving symptoms and quality of life with fewer relapses.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

The new system helps detect and track early female hair loss better.

Dupilumab effectively treated severe alopecia areata in a child.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

Alopecia areata greatly affects quality of life, especially mental health, and newer assessment tools better capture this impact than older ones.

Topical tofacitinib is effective and safe for treating alopecia areata.